Detalhe da pesquisa
1.
Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484130
2.
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.
Am J Respir Crit Care Med
; 209(6): 647-669, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38174955
3.
PCSK6 and Survival in Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 207(11): 1515-1524, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780644
4.
A Phase IIb Randomized Clinical Study of an Anti-αvß6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 206(9): 1128-1139, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35771569
5.
Visual and morphometric description of feral horse hooves from Sable Island National Park Reserve.
Can Vet J
; 64(11): 1028-1034, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37915781
6.
Effects of nintedanib by inclusion criteria for progression of interstitial lung disease.
Eur Respir J
; 59(2)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210788
7.
Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden.
Respirology
; 27(1): 66-75, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34611971
8.
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia.
Am J Respir Crit Care Med
; 203(2): 211-220, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32721166
9.
Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.
Am J Respir Crit Care Med
; 201(10): 1230-1239, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32011901
10.
Patient Registries in Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 200(2): 160-167, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31034241
11.
Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis.
Respir Res
; 20(1): 55, 2019 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30866942
12.
Peripheral Blood Telomere Attrition in Persons at Risk for Familial Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 207(2): 208-211, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036734
13.
A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 197(1): 94-103, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28787186
14.
Identification of a Genetic Susceptibility Locus for Idiopathic Pulmonary Fibrosis in the 16p Subtelomere Using Whole-Genome Sequencing.
Am J Respir Crit Care Med
; 207(7): 941-944, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603154
15.
Female Sex and Gender in Lung/Sleep Health and Disease. Increased Understanding of Basic Biological, Pathophysiological, and Behavioral Mechanisms Leading to Better Health for Female Patients with Lung Disease.
Am J Respir Crit Care Med
; 198(7): 850-858, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29746147
16.
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
N Engl J Med
; 370(22): 2083-92, 2014 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24836312
17.
An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP).
Respiration
; 94(5): 408-415, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28898890
18.
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis.
Thorax
; 71(5): 429-35, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26968970
19.
Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function.
Eur Respir J
; 48(3): 843-51, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27471208
20.
FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis.
Eur Respir J
; 47(5): 1481-91, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26965296